PGY2 Investigational Drugs and Research Pharmacy Residency at Miami Cancer Institute

The Post-Graduate Year 2 (PGY2) Investigational Drugs and Research Pharmacy Residency Program at the Miami Cancer Institute, located on the Baptist Hospital campus, is a 52-week pharmacy specialty-training program accredited by the American Society of Health-System Pharmacists (ASHP). The purpose of the program is to develop well-rounded Investigational Drug Service pharmacists and effective clinical instructors who can provide high-level clinical care in in the research setting, effectively share their knowledge, and promote learning among students and other residents.

The residency program provides exposure to the regulatory and operational requirements that govern clinical research and to cultivate skills necessary to provide clinical care to research participants in the medical oncology and hematologic setting. The training is coordinated to allow residents to master the competencies established within the ASHP practice standards for the PGY2 residency in Investigational Drugs and Research. Residents will develop expertise in implementing and managing clinical trials, collaborating with multidisciplinary teams to promote safe and effective patient care, and advancing pharmacy practice within the clinical research enterprise. In addition, residents will develop skills in leadership, research and teaching through projects, staff education and co-precepting PGY1 residents and pharmacy students.

The Miami Cancer Institute Pharmacy Team was awarded the 2022 Warren E. Weaver/Richard P. Penna Award by the Board of Pharmacy Specialties (BPS) recognized for the organization's commitment to advancing health equity and patient care. The department has over 30 board-certified pharmacists, several of whom carry dual board certification, and residency preceptors within all specialized practice environments in oncology including breast, lung, head and neck, skin, genitourinary, gastrointestinal, gynecologic cancers, neuro oncology, hematology, bone marrow transplant, and cellular therapy, investigational drug therapies, and pediatric hematology and oncology. Furthermore, several research pharmacists completed the ASHP Investigational Drug Service certification program and are experienced practitioners in the research setting.

After successful completion of this program, the graduating resident will have the necessary knowledge and skills in order demonstrate clinical and leadership abilities to perform as an Investigational Drug Service clinical specialist.

American Society of Health-System Pharmacists (ASHP) | ID: 33954

Program Size

Program Director

Vivian H. Nguyen, PharmD, BCPS

786-594-7923

Vivian.Nguyen@baptisthealth.net

Program Coordinator

Michelle M. Bustamante, PharmD, BCPPS

786-594-7195

MichelleBu@baptisthealth.net

People

Preceptors Residents

Herbert Wertheim Cancer Institute

The Herbert Wertheim Cancer Institute, located on the campus of Baptist Hospital, is a destination cancer center known for its innovation and precision in cancer care, exceptional patient experience, advanced clinical research and state-of-the-art technology. The impressive roster of clinicians at Herbert Wertheim Cancer Institute includes renowned oncologists; world-recognized, highly sub-specialized cancer experts and surgeons; clinical researchers and genomic scientists. The Center’s advanced radiation oncology program includes the first proton therapy center from South Florida to South America. As Florida's only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, Herbert Wertheim Cancer Institute is part of a deep and functional collaboration that affords patients access to innovative treatments close to home and ensures that the standards of care developed by the multidisciplinary disease management teams match those at MSK. Herbert Wertheim Cancer Institute received awards in leukemia, lymphoma, and myeloma as well as surgery in lung, prostate, and colon cancers in 2023-2024 U.S. News & World Report Best Hospital Rankings.

Baptist Hospital

The flagship facility of Baptist Health South Florida, Baptist Hospital of Miami has been one of the most respected medical centers in South Florida since its founding in 1960 and is today one of America’s most preferred medical centers. With more than 900 beds, it is the largest of Baptist Health’s 12 hospitals. Three Centers of Excellence are housed on the campus: Herbert Wertheim Cancer Institute, Miami Cardiac & Vascular Institute (the largest and most comprehensive cardiovascular facility in the region) and Miami Neuroscience Institute.

Eligibility Requirements and Application Schedule

Our program attracts, educates, and retains exceptional healthcare talent to serve the South Florida community. Program participants will be trained in the Baptist Health Way with a focus on quality, inclusion, compassion, and collaboration.

Eligibility Pre-requisites

Pharm.D. degree from an ACPE accredited college of pharmacy
Completion of an ASHP accredited PGY-1 pharmacy residency (certificate required)
Must obtain a Florida pharmacist’s license

Application Requirements

Prospective residents are required to submit the following:

Curriculum Vitae
Official transcripts from all colleges of pharmacy attended
Three letters of recommendation from professional references utilizing standard form required by PhORCAS™
Personal statement of intent

Acceptance and admission to the program is contingent on submission of all requested materials and meeting all eligibility requirements as determined by the program.

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.

Application Timeline

Where do applicants go to apply? Pharmacy Online Residency Centralized Application Service (PhORCAS™).
When are applications accepted? November to January
When are candidate interviews? January and February
When are candidates matched/notified of acceptance? March
ASHP Resident Matching Program – National Matching Services, Inc.
National Matching Service Code: 675768
When does the program start? July 1st

Curriculum

Core Learning Experiences

Our program curriculum incorporates several core learning rotations typically lasting several weeks, giving trainees exposure to a wide variety of learning experiences throughout the duration of the program.

Rotations – ALL 4 WEEKS EXCEPT WHERE NOTED

Oncology Pharmacy Operations Onboarding (8 weeks) – Includes ASHP Investigational Drug Services Certificate

(8 weeks)

Research Pharmacy Operations

Research Informatics and Trial Activation

Investigational Drug Service Leadership

Clinical Trial Development

Oncology Medication Safety and Quality

Research Patient Care – BMT / Hematology

Research Patient Care – Medical Oncology

Research Patient Care – Pediatric Hematology/Oncology

Longitudinal Learning Experiences

Our program curriculum incorporates several longitudinal rotations, immersing trainees in particular areas of study throughout the entire duration of the training program.

Rotations – ALL 52 WEEKS IN LENGTH

Oncology and Research Pharmacy Practice (including Drug Information, Academia, and Research Committees)

Oncology and Research Pharmacy Operations (Staffing)

Research Projects and Medication Use Process (Oncology or Investigational Drug Service)

Elective Learning Experiences

Our program offers multiple elective rotation experiences including:

Rotations – ALL 4 WEEKS IN LENGTH

Advanced Investigational Drug Service (Moffitt Cancer Center)

Life in South Florida

Sunny days, warm people, and multicultural community - these await you when you join us at Baptist Health South Florida.

Together we’re unstoppable.

As a mission-driven, not-for-profit organization, philanthropy makes the difference between what we can do and what we must do to impact the lives of patients.